Role of interleukin-22 in inflammatory bowel disease
- PMID: 25561785
- PMCID: PMC4277955
- DOI: 10.3748/wjg.v20.i48.18177
Role of interleukin-22 in inflammatory bowel disease
Abstract
Inflammatory bowel disease (IBD) is a chronic inflammatory disease thought to be mediated by the microbiota of the intestinal lumen and inappropriate immune responses. Aberrant immune responses can cause secretion of harmful cytokines that destroy the epithelium of the gastrointestinal tract, leading to further inflammation. Interleukin (IL)-22 is a member of the IL-10 family of cytokines that was recently discovered to be mainly produced by both adaptive and innate immune cells. Several cytokines and many of the transcriptional factors and T regulatory cells are known to regulate IL-22 expression through activation of signal transducer and activator of transcription 3 signaling cascades. This cytokine induces antimicrobial molecules and proliferative and antiapoptotic pathways, which help prevent tissue damage and aid in its repair. All of these processes play a beneficial role in IBD by enhancing intestinal barrier integrity and epithelial innate immunity. In this review, we discuss recent progress in the involvement of IL-22 in the pathogenesis of IBD, as well as its therapeutic potential.
Keywords: Inflammatory bowel disease; Interleukin-22; Signal transducer and activator of transcription 3.
Figures
Similar articles
-
IL-33 and the intestine: The good, the bad, and the inflammatory.Cytokine. 2017 Dec;100:1-10. doi: 10.1016/j.cyto.2017.06.017. Epub 2017 Jul 4. Cytokine. 2017. PMID: 28687373 Free PMC article. Review.
-
Vitamin D signaling in intestinal innate immunity and homeostasis.Mol Cell Endocrinol. 2017 Sep 15;453:68-78. doi: 10.1016/j.mce.2017.04.010. Epub 2017 Apr 12. Mol Cell Endocrinol. 2017. PMID: 28412519 Review.
-
Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease.World J Gastroenterol. 2015 May 21;21(19):5823-30. doi: 10.3748/wjg.v21.i19.5823. World J Gastroenterol. 2015. PMID: 26019446 Free PMC article. Review.
-
Immunopathology of inflammatory bowel disease.World J Gastroenterol. 2014 Jan 7;20(1):6-21. doi: 10.3748/wjg.v20.i1.6. World J Gastroenterol. 2014. PMID: 24415853 Free PMC article. Review.
-
Commentary: the role of the IL-18 system and other members of the IL-1R/TLR superfamily in innate mucosal immunity and the pathogenesis of inflammatory bowel disease: friend or foe?Eur J Immunol. 2004 Sep;34(9):2347-55. doi: 10.1002/eji.200425351. Eur J Immunol. 2004. PMID: 15307167 Review.
Cited by
-
TH17 cell: a double-edged sword in the development of inflammatory bowel disease.Therap Adv Gastroenterol. 2024 Feb 21;17:17562848241230896. doi: 10.1177/17562848241230896. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 38390028 Free PMC article. Review.
-
Overcoming cancer risk in inflammatory bowel disease: new insights into preventive strategies and pathogenesis mechanisms including interactions of immune cells, cancer signaling pathways, and gut microbiota.Front Immunol. 2024 Jan 15;14:1338918. doi: 10.3389/fimmu.2023.1338918. eCollection 2023. Front Immunol. 2024. PMID: 38288125 Free PMC article. Review.
-
Gut microbiota interacts with inflammatory responses in acute pancreatitis.Therap Adv Gastroenterol. 2023 Oct 10;16:17562848231202133. doi: 10.1177/17562848231202133. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 37829561 Free PMC article. Review.
-
Exploring the Potential of Fecal Microbiota Transplantation as a Therapy in Tuberculosis and Inflammatory Bowel Disease.Pathogens. 2023 Sep 9;12(9):1149. doi: 10.3390/pathogens12091149. Pathogens. 2023. PMID: 37764957 Free PMC article. Review.
-
ALDH1A Inhibition Suppresses Colitis and Alters α4β7 Integrin Expression on Activated T Cells in Mdr1a-/- Mice.Nutrients. 2023 Sep 6;15(18):3883. doi: 10.3390/nu15183883. Nutrients. 2023. PMID: 37764666 Free PMC article.
References
-
- Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417–429. - PubMed
-
- Salim SY, Söderholm JD. Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflamm Bowel Dis. 2011;17:362–381. - PubMed
-
- Sonnenberg GF, Fouser LA, Artis D. Functional biology of the IL-22-IL-22R pathway in regulating immunity and inflammation at barrier surfaces. Adv Immunol. 2010;107:1–29. - PubMed
-
- Ouyang W. Distinct roles of IL-22 in human psoriasis and inflammatory bowel disease. Cytokine Growth Factor Rev. 2010;21:435–441. - PubMed
-
- Aujla SJ, Kolls JK. IL-22: a critical mediator in mucosal host defense. J Mol Med (Berl) 2009;87:451–454. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
